Menu
GWAS Study

Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene.

Mahlman M, Karjalainen MK, Huusko JM et al.

28839172 PubMed ID
GWAS Study Type
1117 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MM
Mahlman M
KM
Karjalainen MK
HJ
Huusko JM
AS
Andersson S
KM
Kari MA
TO
Tammela OKT
SU
Sankilampi U
LL
Lehtonen L
MR
Marttila RH
BD
Bassler D
PC
Poets CF
LT
Lacaze-Masmonteil T
DC
Danan C
DC
Delacourt C
PA
Palotie A
ML
Muglia LJ
LP
Lavoie PM
HA
Hadchouel A
RM
Rämet M
HM
Hallman M
Chapter II

Abstract

Summary of the research findings

Bronchopulmonary dysplasia (BPD), the main consequence of prematurity, has a significant heritability, but little is known about predisposing genes. The aim of this study was to identify gene loci predisposing infants to BPD. The initial genome-wide association study (GWAS) included 174 Finnish preterm infants of gestational age 24-30 weeks. Thereafter, the most promising single-nucleotide polymorphisms (SNPs) associated with BPD were genotyped in both Finnish (n = 555) and non-Finnish (n = 388) replication cohorts. Finally, plasma CRP levels from the first week of life and the risk of BPD were assessed. SNP rs11265269, flanking the CRP gene, showed the strongest signal in GWAS (odds ratio [OR] 3.2, p = 3.4 × 10-6). This association was nominally replicated in Finnish and French African populations. A number of other SNPs in the CRP region, including rs3093059, had nominal associations with BPD. During the first week of life the elevated plasma levels of CRP predicted the risk of BPD (OR 3.4, p = 2.9 × 10-4) and the SNP rs3093059 associated nominally with plasma CRP levels. Finally, SNP rs11265269 was identified as a risk factor of BPD (OR 1.8, p = 5.3 × 10-5), independently of the robust antenatal risk factors. As such, in BPD, a potential role for variants near CRP gene is proposed.

60 Finnish ancestry cases, 114 Finnish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1117
Total Participants
GWAS
Study Type
Yes
Replicated
234 European ancestry cases, 25 African ancestry cases, 633 European ancestry controls, 51 African ancestry controls
Replication Participants
European, African unspecified
Ancestry
Finland, France, Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.